No takes yet. Share an insight, caveat, or question.
Systematic review demonstrates improved drug targeting and bioavailability in liver cancer, highlighting safety and efficacy concerns.
Cosma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: